Pegylated interferon alpha-a (40 kDa) has recently been shown to be superior to conventional interferon. Furthermore, in a pilot study, pegylated interferon alpha-2b together with lamivudine was superior to lamivudine monotherapy. Therefore, the pegylated interferons alone or in combination with antiviral agents are likely to be the treatment of the future. Selecting patients for treatment and knowing when to treat them is as important as knowing which medicine to treat them with.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.cld.2004.02.004 | DOI Listing |
Publication Analysis
Top Keywords
pegylated interferon
8
treatment hepatitis
4
interferon
4
hepatitis interferon
4
interferon combination
4
combination therapy
4
therapy pegylated
4
interferon alpha-a
4
alpha-a kda
4
kda superior
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!